Further experimental validation confirmed that knocking down the expression of STING or IRF7 in myeloma cells significantly suppressed the expression of STING and PD‐L1 induced by melphalan or bortezomib (Figure 3L–O). The gene discussed is IRF7; the disease is plasma cell myeloma.